The U.S. FDA expects to complete most of its investigations on omicron in a few weeks

The U.S. Food and Drug Administration (FDA) said that information about the effects of the current vaccine on the omicron variant will be released in the coming weeks. The FDA expects to complete most of the evaluation of omicron "in the next few weeks." The agency said that if necessary, it will work with companies to quickly develop improved versions of the current vaccine. The FDA also pointed out that in the preliminary assessment, PCR and rapid new crown detection tools widely used in the United States are less likely to be affected by the new variants and continue to be effective. $Petros Pharmaceuticals (PTPI.US)$ $Cumberland Pharmaceuticals (CPIX.US)$ $iSpecimen (ISPC.US)$ $Moderna (MRNA.US)$